Role of endothelial cell extracellular signal-regulated kinase(1/2) in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2

Journal of Cell Science

Volumn 112, Issue 15, 1999, Pages 2597-2606

  Giuliani, Roberta ^a   Bastaki, Maria ^b   Coltrini, Daniela ^a   Presta, Marco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Endothelium; ERK; FGF; Signaling; Urokinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR; UROKINASE;

AMINO ACID SUBSTITUTION; ANGIOGENESIS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; AORTA; BUTADIENES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CAPILLARIES; CATTLE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS, SITE-DIRECTED; NEOVASCULARIZATION, PHYSIOLOGIC; NITRILES; RECOMBINANT PROTEINS; SEQUENCE DELETION; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA; BOVINAE;

EID: 0032789302     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
2. Basilico, C. and Moscalelli, D. (1992). The FCF family of growth factors and oncogenes. Adv. Cancer Res. 59, 115-165.
3. Bastaki, M., Nelli, E. E., Dell'Era, P., Rusnati, M., Molinari-Tosatti, M. P., Parolini, S., Auerbach, R., Ruco, L. P., Possati, L. and Presta, M. (1997). Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. Arterioscler. Thromb. Vasc. Biol. 17, 454-464.
4. Besser, D., Presta, M. and Nagamine, Y. (1995). Elucidation of a signaling pathway induced by FGF-2 leading to uPA gene expression in NIH 3T3 fibroblasts. Cell Growth Differ. 6, 1009-1017.
5. Burgess, W. H., Shaheen, A. M., Hampton, B., Donohue, P. J. and Winkles, J. A. (1991). Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis. J. Cell. Biochem. 45, 131-138.
6. Campbell, J. S., Wenderoth, M. P., Hauschka, S. D. and Krebs, E. G. (1995). Differential activation of mitogen-activated protein kinase in response to basic fibroblast growth factor in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 92, 870-874.
7. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R. and Lee, J. C. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-233.
8. D'Angelo, G., Struman, I., Martial, J. and Weiner, R. I. (1995). Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc. Natl. Acad. Sci. USA 92, 6374-6378.
9. Dell'Era, P., Mohammadi, M. and Presta, M. (1999). Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. Mol. Biol. Cell 10, 23-33.
10. Denton, R. M. and Tavaré, J. M. (1995). Does mitogen-activated protein kinase have a role in insulin action? The cases for and against. Eur. J. Biochem. 227, 597-611.
11. Eliceiri, B. P., Klemke, R., Stromblad, S. and Cheresh, D. A. (1998). Integrin ανβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. 140, 1255-1263.
12. Eriksson, A. E., Cousens, L. S., Weaver, L. H. and Matthews, B. W. (1991). Three-dimensional structure of human basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88, 3441-3445.
13. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J. and Rees, D. C. (1996). Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120.
14. Favata M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Van Dyk, D. E., Pitts, W. J., Earl, R. A., Hobbs, F., Copeland, R. A., Magolda, R. L., Scherle, P. A. and Trzaskos, J. M. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
15. Florkiewicz, R. Z. and Sommer, A. (1989). Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc. Natl. Acad. Sci. USA 86, 3978-3981.
16. Fujimori, A., Cheng, S. L., Avioli, L. V. and Civitelli, R. (1991). Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells. Endocrinology 128, 3032-3039.
17. Gardner, A. M. and Johnson, G. L. (1996). Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 271, 14560-14566.
18. Gospodarowicz, D. and Cheng, J. (1986). Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128, 175-184.
19. Gualandris, A. and Presta, M. (1995). Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor. J. Cell. Physiol. 162, 400-409.
20. r 24,000 bFGF. J. Cell. Physiol. 161, 149-159.
21. Gualandris, A., Rusnati, M., Belleri, M., Nelli, E. E., Bastaki, M., Molinari-Tosatti, M. P., Bonardi, F., Parolini, S., Albini, A., Morbidelli, L., Ziche, M., Corallini, A., Possati, L., Vacca, A., Ribatti, D. and Presta, M. (1996). Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ. 7, 147-160.
22. Guimond, S., Maccarana, M., Olwin, B. B., Lindahl, U. and Rapraeger, A. C. (1993). Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4. J. Biol. Chem. 268, 23906-23914.
23. Ilan N., Mahooti S. and Madri A. (1998). Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J. Cell Sci. 111, 3621-3631.
24. Imamura, T., Engleka, K., Zhan, X., Tokita, Y., Forough, R., Roeder, D., Jackson, A., Maier, J. A. M., Hla, T. and Maciag, T. (1990). Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence. Science 249, 1567-1570.
25. Isacchi, A., Statuto, M., Chiesa, R., Bergonzoni, L., Rusnati, M., Sarmientos, P., Ragnotti, G. and Presta, M. (1991). A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. Proc. Natl. Acad. Sci. USA 88, 2628-2632.
26. Johnson, D. E. and Williams, L. T. (1993). Structural and functional diversity in FGF receptor multigene family. Adv. Cancer Res. 60, 1-41.
27. Katsuura, M. and Tanaka, S. (1989). Topographic analysis of human epidermal growth factor by monospecific antibodies and synthetic peptides. J. Biochem. 106, 87-92.
28. Klein, S., Giancotti, F. G., Presta, M., Albelda, S. M., Buck, C. A. and Rifkin, D. B. (1993). Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol. Biol. Cell. 4, 973-982.
29. Kubota, Y., Kleinman, H. K., Martin, G. R. and Lawley, T. J. (1988). Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107, 1589-1598.
30. Li, L., Safran, M., Aviezer, D., Bohlen, P., Seddon, A. P. and Yayon, A. (1994). Diminished heparin binding of a fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis. Biochemistry 33, 10999-11007.
31. Lin, A., Minden, A., Martinetto, H., Claret, F. X., Lange-Carter, C., Mercurio, F., Johnson, G. L. and Karin, M. (1995). Identification of a dual specificity kinase that activates the jun kinase and p38-Mpk2. Science 268, 286-290.
32. Lokker, N. A., Mark, M. R., Luis, E. A., Bennett, G. L., Robbins, K. A., Baker, J. B. and Godowski, P. J. (1992). Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. EMBO J. 11, 2503-2510.
33. Luo, Y., Gabriel, J. L., Wang, F., Zhan, X., Maciag, T., Kan, M. and McKeehan, W. L. (1996). Molecular modeling and deletion mutagenesis implicate the nuclear translocation sequence in structural integrity of fibroblast growth factor-1. J. Biol. Chem. 271, 26876-26883.
34. Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185
35. Mignatti, P., Tauboi, R., Robbins, E. and Rifkin, D. B. (1989). In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor. J. Cell Biol. 108, 671-682.
36. Mignatti, P., Mazzieri, R. and Rifkin, D. B. (1991). Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J. Cell Biol. 113, 1193-1201.
37. Milasincic, D. J., Calera, M. R., Farmer, S. R. and Pilch, P. F. (1996). Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways. Mol. Cell. Biol. 16, 5964-5973.
38. Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, M. and Schlessinger, J. (1996). Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol. 16, 977-989
39. Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R. and Orci, L. (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83, 7297-7301.
40. Moscatelli, D. (1987). High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J. Cell. Physiol 131, 123-130.
41. Neufeld, G. and Gospodarowicz, D. (1985). The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J. Biol. Chem 260, 13860-13868.
42. MAPK are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90, 8319-8323.
43. Pawson, T. (1995). Protein modules and signalling networks. Nature 373, 573-580.
44. Pepper, M. S. and Meda, P. (1992). Basic fibroblast growth factor increases junctional communication and connexin 43 expression in microvascular endothelial cells. J. Cell. Physiol. 153, 196-205.
45. Presta, M., Maier, J. A. M. and Ragnotti, G. (1989). The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J. Cell Biol. 109, 1877-1884.
46. Presta, M., Tiberio, L., Rusnati, M., Dell'Era, P. and Ragnotti, G. (1991). Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. Mol. Biol. Cell. 2, 719-726.
47. Presta, M., Statuto, M., Isacchi, A., Caccia, P., Pozzi, A., Gualandris, A., Rusnati, M., Bergonzoni, L. and Sarmientos, P. (1992). Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region. Biochem. Biophys. Res. Commun. 185, 1098-1107.
48. r 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence. Growth Factors 9, 269-278.
49. Rusnati, M. and Presta, M. (1996). Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int. J. Clin. Lab. Res 26, 15-23.
50. Rusnati, M., Coltrini, D., Caccia, P., Dell'Era, P., Zoppetti, G., Oreste, P., Valsasina, B. and Presta, M. (1994). Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. Biochem. Biophys. Res. Commun. 203, 450-458.
51. Rusnati, M., Dell'Era, P., Urbinati, C., Tanghetti, E., Massardi, M. L., Nagamine, Y., Monti, E. and Presta, M. (1996). A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells. Mol. Biol. Cel 7, 369-381.
52. Saksela, O., Moscatelli, D., Sommer, A. and Rifkin, D. B. (1988). Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107, 743-751.
53. Shanafelt, A. B. and Kastelein, R. A. (1992). High affinity ligand binding is not essential for granulocyte-macrophage colony-stimulating factor receptor activation. J. Biol. Chem. 267, 25466-25472.
54. Spivak-Krolzman, T., Lemmon. M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J. and Lax, I. (1994). Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024.
55. Unson, C. G., Macdonald, D., Ray, K., Durrah, T. L. and Merrifield, R. B. (1991). Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding. J. Biol. Chem. 266, 2763-2766.
56. Zhang, J., Cousens, L. S., Barr, P. J. and Sprang, S. R. (1991). Three-dimensional structure of human basic fibroblast growth factor, a structural homologue of interleukin 1β. Proc. Natl. Acad. Sci. USA 88, 3446-3450.
57. Zhu, X., Komiya, H., Chirino, A., Faham, S., Fox, G. M., Arakawa, T., Hsu, B. T. and Rees, D. C. (1990). Three-dimensional structures of acidic and basic fibroblast growth factors. Science 251, 90-93.